John Jøhnke - Press release

Press release John Jøhnke, Danetto Ingredients A/S

Kære kunder, leverandører og forretningsforbindelser. 

På grund af pludseligt opståede syns problemer hos John Jøhnke varetages den

overordnede ledelse af Danetto af den konstituerede ledelse med John Jøhnke i en

supporterende rolle indtil fuld rekreation. Synsproblemerne skyldes en tumor i

hjernen der påvirker syns- og til dels balanceevnen. Operation foretages fredag d. 19/02

og efterfølgende rekreationsperiode, og efterbehandling forventes at vare mindst 6

måneder. Til trods for den dystre meddelelse så ser fremtidsudsigterne fra alle sider

lyse ud.

Der vil således blive udpeget nye kontaktpersoner til leverandører og kunder og

Danetto garanterer business as usual. Jane Jøhnke, ledergruppen

samt 1-2 nye personer med teknisk samt kommerciel baggrund vil føre firmaet videre

i den nuværende ånd samt være fuldgyldig erstatning for John Jøhnke i den korte tid

det forventes at det tager at komme over denne sygdom der påvirker synet så

kørsel samt fokusering er nedsat i en grad der umuliggør 100% arbejdsindsats fra

John's side af. 

Danetto takker for forståelsen og skulle der være spørgsmål er de velkommen til at ,

kontakte Jane, Peter, ledergruppen eller prøve at fange John Jøhnke på mobilen.

Dear Customers, Suppliers and Business Connections.

Due to John Jøhnke's sudden eyesight problems the executive control of Danetto will be handled by the acting direction with John Jøhnke in a supporting role until full recovery has been reached. The sudden eyesight problems are due to a brain tumor which affects the optic nerve. The eyesight problems affects John's work performance in such a way that a 100% work rate is unattainable until the illness is properly treated. An operation on John was performed Friday the 19th February, which was thankfully a successful one. John is already back to work to an extent of which he himself handles. As a result of the operation a recovery period of around 3 weeks is to be expected. As with nearly all tumors a post-operation treatment period of around 6 months is needed to reach full recovery. In spite of this somber news the future prospects for Danetto and its partners look as bright as they always have. As a consequence new contacts within Danetto will be appointed to service both suppliers and customers, and Danetto guaranties that business will go on as usual. Jane Jøhnke, Peter Kristensen and the direction along with one or two new employees with technical and commercial backgrounds in the field will lead the company onwards in the Danetto spirit and at the same time be replacements for John Jøhnke in the short period in which the treatment will proceed. Danetto thanks you for your understanding in this difficult time. If any questions come to mind feel free to call, email or fax Jane Jøhnke, Peter Kristensen, the direction or John himself.

Best Regards,

Danetto Ingredients A/S